Genetics
Home › Medical research › Parkinson's disease
Insufficient evidence

Parkinson's disease & cannabis

The 2017 National Academies review found insufficient evidence that cannabinoids improve Parkinson’s motor symptoms or levodopa-induced dyskinesia. This does not establish cannabis as a Parkinson’s treatment.

Sources: NASEM 2017

Most-studied cannabinoids

THCCBD

Safety & cautions

Mixed results; caution in older adults.

Clinical research below concerns cannabis or cannabinoids, not evidence that a named cultivar treats a condition.

Help us build this responsibly

This page reflects the cited published clinical evidence, and it is a work in progress. Areto is committed to expanding and refining it as new research emerges — so it can genuinely help medical patients make informed choices. If you are a clinician, researcher, or patient with peer-reviewed sources to add, email us at genetics@areto.tech.

Areto Genetics is an educational cannabis catalog. Nothing here is medical advice, and no strain is proven to treat, cure, or prevent any disease. Cannabis affects people differently and carries real risks. Talk to a qualified healthcare provider before using cannabis for any condition — especially if you are pregnant or breastfeeding, an adolescent, taking other medications, or have a heart, liver, or psychiatric condition.